[go: up one dir, main page]

AU2001290220A1 - High level expression of heterologous proteins - Google Patents

High level expression of heterologous proteins

Info

Publication number
AU2001290220A1
AU2001290220A1 AU2001290220A AU9022001A AU2001290220A1 AU 2001290220 A1 AU2001290220 A1 AU 2001290220A1 AU 2001290220 A AU2001290220 A AU 2001290220A AU 9022001 A AU9022001 A AU 9022001A AU 2001290220 A1 AU2001290220 A1 AU 2001290220A1
Authority
AU
Australia
Prior art keywords
high level
level expression
heterologous proteins
heterologous
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290220A
Inventor
Oren Bogin
Yigal Burstein
Moshe Peretz
Avner Yayon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prochon Biotech Ltd
Yeda Research and Development Co Ltd
Original Assignee
Prochon Biotech Ltd
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prochon Biotech Ltd, Yeda Research and Development Co Ltd filed Critical Prochon Biotech Ltd
Publication of AU2001290220A1 publication Critical patent/AU2001290220A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001290220A 2000-09-18 2001-09-16 High level expression of heterologous proteins Abandoned AU2001290220A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13852900A IL138529A0 (en) 2000-09-18 2000-09-18 High level expression of heterologous proteins
IL138529 2000-09-18
PCT/IL2001/000870 WO2002022779A2 (en) 2000-09-18 2001-09-16 High level expression of heterologous proteins

Publications (1)

Publication Number Publication Date
AU2001290220A1 true AU2001290220A1 (en) 2002-03-26

Family

ID=11074649

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290220A Abandoned AU2001290220A1 (en) 2000-09-18 2001-09-16 High level expression of heterologous proteins

Country Status (4)

Country Link
US (1) US7264946B2 (en)
AU (1) AU2001290220A1 (en)
IL (2) IL138529A0 (en)
WO (1) WO2002022779A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149562A0 (en) 2002-05-09 2002-11-10 Prochon Ltd Fgf variants and methods for use thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US8497081B2 (en) 2004-02-24 2013-07-30 Allergan, Inc. Botulinum toxin screening assays
JP4970057B2 (en) * 2004-02-24 2012-07-04 アラーガン、インコーポレイテッド Botulinum toxin screening assay
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
EP1885847B1 (en) * 2005-05-26 2011-07-06 Cytos Biotechnology AG Scalable fermentation process
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP2009508596A (en) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション Cell support substrate and preparation method thereof
US8962556B2 (en) 2006-09-28 2015-02-24 Prochon Biotech Ltd. FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN110777165B (en) * 2019-06-21 2021-08-06 梦芊科技知识产权有限公司 Enhancer sequence and plasmid vector and its preparation method and application and transformant
CN110777148B (en) * 2019-06-21 2021-08-06 梦芊科技知识产权有限公司 DNA sequence for expressing FGF-2 and method for preparing FGF-2
CN118879716A (en) * 2024-09-30 2024-11-01 江苏凯基生物技术股份有限公司 A method for preparing nucleic acid, recombinant plasmid and recombinant human FGF-9 protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891704A (en) * 1992-11-19 1999-04-06 Anticancer, Inc. Method to produce high levels of methioninase
US5891855A (en) * 1996-02-12 1999-04-06 The Scripps Research Institute Inhibitors of leaderless protein export
US5908924A (en) * 1996-02-27 1999-06-01 Michigan State University Cloning and expression of the gene encoding thermoanaerobacter ethanolicus 39E secondary-alcohol dehydrogenase and enzyme biochemical characterization

Also Published As

Publication number Publication date
WO2002022779A3 (en) 2003-01-09
WO2002022779A2 (en) 2002-03-21
IL154209A (en) 2011-04-28
US7264946B2 (en) 2007-09-04
IL138529A0 (en) 2003-09-17
US20040058348A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2002223504A1 (en) Heterologous expression of taxanes
AU2001280201A1 (en) Methods of synthesizing cell-free protein
AU2002227435A1 (en) Antisense modulation of calreticulin expression
AU2001290220A1 (en) High level expression of heterologous proteins
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001289085A1 (en) Antisense modulation of flip-c expression
AU2001293564A1 (en) Point of sale terminal
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
AU2001291049A1 (en) Defensin-antigen fusion proteins
AU2001241075A1 (en) Method of anticipating interaction between proteins
AU2002211652A1 (en) Method of making an electrode
AU2001275007A1 (en) Methods of testing materials
AU2001278739A1 (en) Method of modifying microorganism-origin transglutaminase
AU2002214286A1 (en) Method of profiling protein
AU2001227847A1 (en) Antisense modulation of pepck-cytosolic expression
AU2000275763A1 (en) Expression of functional eukaryotic proteins
AU2001287136A1 (en) Antisense modulation of glioma-associated oncogene-1 expression
AU2002227035A1 (en) Methods of stabilizing fruit-concentrate powders
AU2002248557A1 (en) High level insect expression of rage proteins
AU2002348573A1 (en) Method of increasing expression of heterologous proteins in plants
AU2000270368A1 (en) Gcn4-derived expression of heterologous coding sequences
AU2001262589A1 (en) Glycosyltransferase proteins
IL154209A0 (en) High level expression of heterologous proteins
AU2002245089A1 (en) Antisense modulation of cytohesin-1 expression
AU2001260220A1 (en) Method for modification of proteins by transglutaminase